Keenova Reports First Quarter 2026 Financial Results | MNK Stock NewsStockTitan·May 11 at 09:30 PMSEOVF+4.37%ITRM0.00%
08:09 ETIterion Therapeutics Announces Oral Presentation of Phase 1/2 Tegavivint Data in Advanced Hepatocellular Carcinoma at the 2026 ASCO Annual Meetingprnewswire·May 4 at 07:09 AMITRM0.00%
Keenova Launches New Consumer Campaign for Dupuytren's Contracture: Don't Be a Viking | MNK Stock NewsStockTitan·May 3 at 10:30 PMNBRVF0.00%ITRM0.00%
Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week | MNK Stock NewsStockTitan·Apr 30 at 10:30 PMITRM0.00%NBRVF0.00%
Antibiotic resistance is growing — don't delay new antibioticsThehill·Apr 29 at 11:12 AMITRM0.00%ITRMF0.00%
Iterion Presents New Data on First-in-Class TBL1 Inhibitor Tegavivint, Targeting Wnt-Driven Cancers at AACR Annual MeetingMorningStar·Apr 13 at 07:20 AMITRM0.00%IHE+0.38%
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga_article·Mar 31 at 04:05 PMIINN0.00%LABU-3.22%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Mar 31 at 12:05 PMBBH-0.23%VRAX0.00%
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Mar 31 at 07:05 AMBBH-0.23%LABU-3.22%
06:30 ETKeenova Announces Unaudited Fourth Quarter 2025 Financial Resultsprnewswire·Mar 31 at 05:30 AMLABU-3.22%BBH-0.23%
Pre-market hot trades in US stocks: System1 up 13.67% in pre-market; Iterum Therap down 11.79% in pre-marketPrice Alert·Mar 31 at 03:37 AMSST+1.10%ITRM0.00%
